ScholarWorks@SUNGKYUNKWAN UNIVERSITY

British Journal of Cancer

Journal Title

  • British Journal of Cancer

ISSN

  • E 1532-1827 | P 0007-0920 | 1532-1827 | 0007-0920

Publisher

  • Nature Publishing Group
  • Springer Nature

Listed on(Coverage)

JCR1997-2019
SJR1999-2019
CiteScore2011-2019
SCI2010-2019
SCIE2010-2021
CC2016-2021
SCOPUS2017-2020
MEDLINE2016-2021
EMBASE2016-2020

Active

  • Active

    based on the information

    • SCOPUS:2020-10

Country

  • ENGLAND

Aime & Scopes

  • The British Journal of Cancer is one of the most-cited general cancer journals, publishing significant advances in translational and clinical cancer research. It also publishes high-quality reviews and thought-provoking comment on all aspects of cancer prevention, diagnosis and treatment. BJC welcomes research across all cancer types and has a particular focus on: metastasis, microenvironment, immunology and immunotherapy, targeted and next-generation therapeutics, chemotherapy and radiotherapy, mechanisms of resistance, clinical trials, genomics, epigenomics and precision medicine, epidemiology, metabolism and state-of-the art diagnostic approaches. The British Journal of Cancer is owned by Cancer Research UK, the world’s leading cancer charity dedicated to saving lives through research. The journal is separated into six general categories: /// Clinical Studies /// Translational Therapeutics /// Molecular Diagnostics /// Genetics and Genomics /// Cellular and Molecular Biology /// Epidemiology

Homepage

Article List

1 - 20 out of 50 results.

SCIESCOPUS
Adherence to the World Cancer Research Fund/American Institute for Cancer Research cancer prevention recommendations throughout the life course and risk of colorectal cancer precursors

Zhang, S.[Zhang, S.]; Hur, J.[Hur, J.]; Song, R.[Song, R.]; Wang, P.[Wang, P.]; Cao, Y.[Cao, Y.]; Wu, K.[Wu, K.]; Giovannucci, E.[Giovannucci, E.]

ArticleIssue Date2023CitationBritish Journal of Cancer, v.128, no.12, pp.2243 - 2252PublisherSpringer Nature
SCIESCOPUS
Reply to comment(s) on "Development and validation of a novel strong prognostic index for colon cancer through a robust combination of laboratory features for systemic inflammation: a prognostic immune nutritional index"

Jung, SH[Jung, Sang-Hyuk]; Dokyoon,[Kim, Dokyoon]; Park, JW[Park, Ji Won]

ArticleIssue Date2022CitationBRITISH JOURNAL OF CANCER, v.127, no.1, pp.170 - 171PublisherSPRINGERNATURE
SCIESCOPUS
Development and validation of a novel strong prognostic index for colon cancer through a robust combination of laboratory features for systemic inflammation: a prognostic immune nutritional index

Jung, SH[Jung, Sang-Hyuk]; Hao, J[Hao, Jie]; Shivakumar, M[Shivakumar, Manu]; Nam, Y[Nam, Yonghyun]; Kim, J[Kim, Jaesik]; Kim, MJ[Kim, Min Jung]; Ryoo, SB[Ryoo, Seung-Bum]; Choe, EK[Choe, Eun Kyung]; Jeong, SY[Jeong, Seung-Yong]; Park, KJ[Park, Kyu Joo], et al.

ArticleIssue Date2022CitationBRITISH JOURNAL OF CANCER, v.126, no.11, pp.1539 - 1547PublisherSPRINGERNATURE
SCIESCOPUS
Randomised Phase 1b/2 trial of tepotinib vs sorafenib in Asian patients with advanced hepatocellular carcinoma with MET overexpression

Ryoo, BY[Ryoo, Baek-Yeol]; Cheng, AL[Cheng, Ann-Li]; Ren, ZG[Ren, Zhenggang]; Kim, TY[Kim, Tae-You]; Pan, HM[Pan, Hongming]; Rau, KM[Rau, Kun-Ming]; Choi, HJ[Choi, Hye Jin]; Park, JW[Park, Joong-Won]; Kim, JH[Kim, Jee Hyun]; Yen, CJ[Yen, Chia Jui], et al.

ArticleIssue Date2021CitationBRITISH JOURNAL OF CANCER, v.125, no.2, pp.200 - 208PublisherSPRINGERNATURE
SCIESCOPUS
A multicentre, randomised, open-label, parallel-group Phase 2b study of belotecan versus topotecan for recurrent ovarian cancer

Kim, HS[Kim, Hee Seung]; Park, SY[Park, Sang-Yoon]; Park, CY[Park, Chan-Yong]; Kim, YT[Kim, Young Tae]; Kim, BJ[Kim, Beob-Jong]; Song, YJ[Song, Yong Jung]; Kim, BG[Kim, Byoung-Gie]; Kim, YB[Kim, Yong Beom]; Cho, CH[Cho, Chi-Heum]; Kim, JH[Kim, Jong-Hyeok], et al.

ArticleIssue Date2021CitationBRITISH JOURNAL OF CANCER, v.124, no.2, pp.375 - 382PublisherSPRINGERNATURE
SCIESCOPUS
Mouse-human co-clinical trials demonstrate superior anti-tumour effects of buparlisib (BKM120) and cetuximab combination in squamous cell carcinoma of head and neck

Kim, HR[Kim, Hye Ryun]; Kang, HN[Kang, Han Na]; Yun, MR[Yun, Mi Ran]; Ju, KY[Ju, Kwon Young]; Choi, JW[Choi, Jae Woo]; Jung, DM[Jung, Dong Min]; Pyo, KH[Pyo, Kyoung Ho]; Hong, MH[Hong, Min Hee]; Ahn, MJ[Ahn, Myoung-Ju]; Sun, JM[Sun, Jong-Mu], et al.

ArticleIssue Date2020CitationBRITISH JOURNAL OF CANCER, v.123, no.12, pp.1720 - 1729PublisherSPRINGERNATURE
SCIESCOPUS
MicroRNA-17-5p regulates EMT by targeting vimentin in colorectal cancer (Jun, 10.1038/S41416-020-0940-5, 2020)

Kim, TW[Kim, Tae Won]; Lee, YS[Lee, Yeo Song]; Yun, NH[Yun, Nak Hyeon]; Shin, CH[Shin, Chang Hoon]; Hong, HK[Hong, Hye Kyung]; Kim, HH[Kim, Hyeon Ho]; Cho, YB[Cho, Yong Beom]

ArticleIssue Date2020CitationBRITISH JOURNAL OF CANCER, v.123, no.7, pp.1204 - 1204PublisherSPRINGERNATURE
SCIESCOPUS
MicroRNA-17-5p regulates EMT by targeting vimentin in colorectal cancer

Kim, TW[Kim, Tae Won]; Lee, YS[Lee, Yeo Song]; Yun, NH[Yun, Nak Hyeon]; Shin, CH[Shin, Chang Hoon]; Hong, HK[Hong, Hye Kyung]; Kim, HH[Kim, Hyeon Ho]; Cho, YB[Cho, Yong Beom]

ArticleIssue Date2020CitationBRITISH JOURNAL OF CANCER, v.123, no.7, pp.1123 - 1130PublisherNATURE PUBLISHING GROUP
SCIESCOPUS
Phase 1 study of MRX34, a liposomal miR-34a mimic, in patients with advanced solid tumours

Hong, DVS[Hong, David S.]; Kang, YK[Kang, Yoon-Koo]; Borad, M[Borad, Mitesh]; Sachdev, J[Sachdev, Jasgit]; Ejadi, S[Ejadi, Samuel]; Lim, HY[Lim, Ho Yeong]; Brenner, AJ[Brenner, Andrew J.]; Park, K[Park, Keunchil]; Lee, JL[Lee, Jae-Lyun]; Kim, TY[Kim, Tae-You], et al.

ArticleIssue Date2020CitationBRITISH JOURNAL OF CANCER, v.122, no.11, pp.1630 - 1637PublisherNATURE PUBLISHING GROUP
SCIESCOPUS
Female reproductive factors and the risk of lung cancer in postmenopausal women: a nationwide cohort study

Jeon, KH[Jeon, Keun Hye]; Shin, DW[Shin, Dong Wook]; Han, K[Han, Kyungdo]; Kim, D[Kim, Dahye]; Yoo, JE[Yoo, Jung Eun]; Jeong, SM[Jeong, Su-Min]; Cho, JH[Cho, Jong Ho]

ArticleIssue Date2020CitationBRITISH JOURNAL OF CANCER, v.122, no.9, pp.1417 - 1424PublisherNATURE PUBLISHING GROUP
SCIESCOPUS
Randomised Phase 2 study of lapatinib and vinorelbine vs vinorelbine in patients with HER2 + metastatic breast cancer after lapatinib and trastuzumab treatment (KCSG BR11-16)open access

Sim S.H.[Sim S.H.]; Park I.H.[Park I.H.]; Jung K.H.[Jung K.H.]; Kim S.-B.[Kim S.-B.]; Ahn J.-H.[Ahn J.-H.]; Lee K.-H.[Lee K.-H.]; Im S.-A.[Im S.-A.]; Im Y.-H.[Im Y.-H.]; Park Y.H.[Park Y.H.]; Sohn J.[Sohn J.], et al.

ArticleIssue Date2019CitationBritish Journal of Cancer, v.121, no.12, pp.985 - 990PublisherSpringer Nature
SCIESCOPUS
A multi-national, randomised, open-label, parallel, phase III non-inferiority study comparing NK105 and paclitaxel in metastatic or recurrent breast cancer patientsopen access

Fujiwara, Y[Fujiwara, Yasuhiro]; Mukai, H[Mukai, Hirofumi]; Saeki, T[Saeki, Toshiaki]; Ro, J[Ro, Jungsil]; Lin, YC[Lin, Yung-Chang]; Nagai, SE[Nagai, Shigenori E.]; Lee, KS[Lee, Keun Seok]; Watanabe, J[Watanabe, Junichiro]; Ohtani, S[Ohtani, Shoichiro]; Kim, SB[Kim, Sung Bae], et al.

ArticleIssue Date2019CitationBRITISH JOURNAL OF CANCER, v.120, no.5, pp.475 - 480PublisherNATURE PUBLISHING GROUP
SCIESCOPUS
Prognostic impact of CD8 and programmed death-ligand 1 expression in patients with resectable non-small cell lung canceropen access

Kim, SH[Kim, Seok-Hyun]; Go, SI[Go, Se-Il]; Song, DH[Song, Dae Hyun]; Park, SW[Park, Sung Woo]; Kim, HR[Kim, Hye Ree]; Jang, I[Jang, Inseok]; Kim, JD[Kim, Jong Duk]; Lee, JS[Lee, Jong Sil]; Lee, GW[Lee, Gyeong-Won]

ArticleIssue Date2019CitationBRITISH JOURNAL OF CANCER, v.120, no.5, pp.547 - 554PublisherNATURE PUBLISHING GROUP
SCIESCOPUS
Outcomes based on prior therapy in the phase 3 METEOR trial of cabozantinib versus everolimus in advanced renal cell carcinomaopen access

Powles, T.[Powles, T.]; Motzer, R.J.[Motzer, R.J.]; Escudier, B.[Escudier, B.]; Pal, S.[Pal, S.]; Kollmannsberger, C.[Kollmannsberger, C.]; Pikiel, J.[Pikiel, J.]; Gurney, H.[Gurney, H.]; Rha, S.Y.[Rha, S.Y.]; Park, S.H.[Park, S.H.]; Geertsen, P.F.[Geertsen, P.F.], et al.

ArticleIssue Date2018CitationBritish Journal of Cancer, v.119, no.6, pp.663 - 669PublisherNature Publishing Group
SCIESCOPUS
Cigarette smoking and thyroid cancer risk: a cohort studyopen access

Cho, A[Cho, Ara]; Chang, Y[Chang, Yoosoo]; Ahn, J[Ahn, Jiin]; Shin, H[Shin, Hocheol]; Ryu, S[Ryu, Seungho]

ArticleIssue Date2018CitationBRITISH JOURNAL OF CANCER, v.119, no.5, pp.638 - 645PublisherNATURE PUBLISHING GROUP
SCIESCOPUS
Predicting cumulative incidence of adverse events in older patients with cancer undergoing first-line palliative chemotherapy: Korean Cancer Study Group (KCSG) multicentre prospective studyopen access

Kim, JW[Kim, Jin Won]; Lee, YG[Lee, Yun-Gyoo]; Hwang, IG[Hwang, In Gyu]; Song, HS[Song, Hong Suk]; Koh, SJ[Koh, Su Jin]; Ko, YH[Ko, Yoon Ho]; Shin, SH[Shin, Seong Hoon]; Woo, IS[Woo, In Sook]; Hong, S[Hong, Soojung]; Kim, TY[Kim, Tae-Yong], et al.

ArticleIssue Date2018CitationBRITISH JOURNAL OF CANCER, v.118, no.9, pp.1169 - 1175PublisherNATURE PUBLISHING GROUP
SCIESCOPUS
Pazopanib maintenance after first-line etoposide and platinum chemotherapy in patients with extensive disease small-cell lung cancer: a multicentre, randomised, placebo-controlled Phase II study (KCSG-LU12-07)open access

Sun, JM[Sun, Jong-Mu]; Lee, KH[Lee, Ki Hyeong]; Kim, BS[Kim, Bong-Seog]; Kim, HG[Kim, Hoon-Gu]; Min, YJ[Min, Young Joo]; Yi, SY[Yi, Seong Yoon]; Yun, HJ[Yun, Hwan Jung]; Jung, SH[Jung, Sin-Ho]; Lee, SH[Lee, Se-Hoon]; Ahn, JS[Ahn, Jin Seok], et al.

ArticleIssue Date2018CitationBRITISH JOURNAL OF CANCER, v.118, no.5, pp.648 - 653PublisherNATURE PUBLISHING GROUP
SCIESCOPUS
Inhibitor of DNA binding 2 is a novel therapeutic target for stemness of head and neck squamous cell carcinomaopen access

Bae, WJ[Bae, Woo Jin]; Koo, BS[Koo, Bon Seok]; Lee, SH[Lee, Sang Hyuk]; Kim, JM[Kim, Jin Man]; Rho, YS[Rho, Young Soo]; Lim, JY[Lim, Jae Yol]; Moon, JH[Moon, Jung Hwa]; Cho, JH[Cho, Jae Hoon]; Lim, YC[Lim, Young Chang]

ArticleIssue Date2017CitationBRITISH JOURNAL OF CANCER, v.117, no.12, pp.1810 - 1818PublisherNATURE PUBLISHING GROUP
SCIESCOPUS
Randomised Phase 2 study of maintenance linsitinib (OSI-906) in combination with erlotinib compared with placebo plus erlotinib after platinum-based chemotherapy in patients with advanced non-small cell lung canceropen access

Ciuleanu, TE[Ciuleanu, Tudor-Eliade]; Ahmed, S[Ahmed, Samreen]; Kim, JH[Kim, Joo-Hang]; Mezger, J[Mezger, Joerg]; Park, K[Park, Keunchil]; Thomas, M[Thomas, Michael]; Chen, JH[Chen, Jihong]; Poondru, S[Poondru, Srinivasu]; VanTornout, JM[VanTornout, Jan M.]; Whitcomb, D[Whitcomb, Debbie], et al.

ArticleIssue Date2017CitationBRITISH JOURNAL OF CANCER, v.117, no.6, pp.757 - 766PublisherNATURE PUBLISHING GROUP
SCIESCOPUS
A phase 3 trial evaluating panitumumab plus best supportive care vs best supportive care in chemorefractory wild-type KRAS or RAS metastatic colorectal canceropen access

Kim, TW[Kim, Tae Won]; Elme, A[Elme, Anneli]; Kusic, Z[Kusic, Zvonko]; Park, JO[Park, Joon Oh]; Udrea, AA[Udrea, Anghel Adrian]; Kim, SY[Kim, Sun Young]; Ahn, JB[Ahn, Joong Bae]; Valencia, RV[Villalobos Valencia, Ricardo]; Krishnan, S[Krishnan, Srinivasan]; Bilic, A[Bilic, Ante], et al.

ArticleIssue Date2016CitationBRITISH JOURNAL OF CANCER, v.115, no.10, pp.1206 - 1214PublisherNATURE PUBLISHING GROUP
1 2 3
STATISTICS
Total View :5,487,954
Today View :3,229

RSS_1.0 RSS_2.0 ATOM_1.0

CONTACT US

(03063) 25-2, SUNGKYUNKWAN-RO, JONGNO-GU, SEOUL, KOREAsamsunglib@skku.edu

COPYRIGHT © 2021 SUNGKYUNKWAN UNIVERSITY ALL RIGHTS RESERVED.

Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.

BROWSE

한국어